All in the family: VEGF-B joins the ranks of proangiogenic cytokines

Circ Res. 2003 Jul 25;93(2):87-90. doi: 10.1161/01.RES.0000084992.10766.36.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Cytokines / genetics
  • Cytokines / pharmacology
  • Cytokines / physiology*
  • Endothelial Growth Factors / genetics
  • Endothelial Growth Factors / pharmacology
  • Endothelial Growth Factors / physiology*
  • Humans
  • Mice
  • Myocardial Ischemia / drug therapy
  • Neovascularization, Physiologic / drug effects
  • Neovascularization, Physiologic / physiology*
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Peripheral Vascular Diseases / drug therapy
  • Protein Serine-Threonine Kinases*
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-akt
  • Signal Transduction / physiology
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor B
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism

Substances

  • Cytokines
  • Endothelial Growth Factors
  • Proto-Oncogene Proteins
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor B
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse
  • Vascular Endothelial Growth Factor Receptor-1
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt